| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.04 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.061 | 0.05 |